[1] Zanon Zotin MC, Sveikata L, Viswanathan A, Yilmaz P. Cerebral small vessel disease and vascular cognitive impairment:from diagnosis to management[J]. Curr Opin Neurol, 2021, 34:246-257. [2] Markus HS, de Leeuw FE. Cerebral small vessel disease:recent advances and future directions[J]. Int J Stroke, 2023, 18:4-14. [3] Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw FE, Debette S, Frayne R, Jouvent E, Rost NS, Ter Telgte A, Al-Shahi Salman R, Backes WH, Bae HJ, Brown R, Chabriat H, De Luca A, deCarli C, Dewenter A, Doubal FN, Ewers M, Field TS, Ganesh A, Greenberg S, Helmer KG, Hilal S, Jochems ACC, Jokinen H, Kuijf H, Lam BYK, Lebenberg J, MacIntosh BJ, Maillard P, Mok VCT, Pantoni L, Rudilosso S, Satizabal CL, Schirmer MD, Schmidt R, Smith C, Staals J, Thrippleton MJ, van Veluw SJ, Vemuri P, Wang Y, Werring D, Zedde M, Akinyemi RO, Del Brutto OH, Markus HS, Zhu YC, Smith EE, Dichgans M, Wardlaw JM. Neuroimaging standards for research into small vessel disease:advances since 2013[J]. Lancet Neurol, 2023, 22:602-618. [4] Xu Y, Huang D, Zhang H, Fang Q, Xia Y, Shi F, Gong X. White matter hyperintensities regress at a high rate at three months after minor ischemic stroke or transient ischemic attack[J]. J Neuroradiol, 2025, 52:101239. [5] Ntaios G, Lip GY, Lambrou D, Papavasileiou V, Manios E, Milionis H, Spengos K, Makaritsis K, Vemmos K. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation[J]. Neurology, 2015, 84:1213-1219. [6] Gwak DS, Ryu WS, Schellingerhout D, Chung J, Kim HR, Jeong SW, Kim BJ, Kim JT, Hong KS, Park JM, Park MS, Choi KH, Park TH, Lee K, Park SS, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Lee JS, Bae HJ, Kim DE. Effects of white matter hyperintensity burden on functional outcome after mild versus moderate-to-severe ischemic stroke[J]. Sci Rep, 2024, 14:22567. [7] Derraz I, Abdelrady M, Ahmed R, Gaillard N, Morganti R, Cagnazzo F, Dargazanli C, Lefevre PH, Riquelme C, Corti L, Gascou G, Mourand I, Arquizan C, Costalat V. Impact of white matter hyperintensity burden on outcome in large-vessel occlusion stroke[J]. Radiology, 2022, 304:145-152. [8] Fan H, Wei L, Zhao X, Zhu Z, Lu W, Roshani R, Huang K. White matter hyperintensity burden and functional outcomes in acute ischemic stroke patients after mechanical thrombectomy:a systematic review and meta-analysis[J]. Neuroimage Clin, 2024, 41:103549. [9] Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of atuce ischemic stroke 2023[J]. Zhonghua Shen Jing Ke Za Zhi, 2024, 57:523-559.[中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性卒中诊治指南2023[J].中华神经科杂志, 2024, 57:523-559.] [10] Chinese Nutrition Society Obesity Prevention and Control Section; Chinese Nutrition Society Clinical Nutrition Section; Chinese Preventive Medicien Association Behavioral Health Section; Chinese Preventive Medecine Association Sports and Health Seaction. Expert consensus on obesity prevention and treatment in China[J]. Xi'an Jiao Tong Da Xue Xue Bao (Yi Xue Ban), 2022, 43:619-631.[中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,中华预防医学会体育运动与健康分会.中国居民肥胖防治专家共识[J].西安交通大学学报(医学版), 2022, 43:619-631.] [11] Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150:604-612. [12] Chen WQ, Xu JJ, Lu Y, Wang L, Cao JY, Chen HB, Guo L, Lü YC, Tang H, Wang Z, Xu FF, Yan TM, Ying YQ, Zhong WY, Zhou R, Lu ZQ, Cheng X, Wang YL; Small Vessel Disease Branch of Chinese Stroke Associoation. Neuroimaging diagnostic criteria and standardized definition of terms for small vessel disease in China:expert consensus from the Chinese stroke association[J]. Zhongguo Zu Zhong Za Zhi, 2024, 19:375-404.[陈玮琪,徐佳洁,陆瑶,王玲,曹瑾怡,陈鸿宾,郭蕾,吕琰琛,汤晗,王赞,徐非凡,颜庭梦,应云清,仲伟逸,周蓉,陆正齐,程忻,王伊龙,中国卒中学会脑小血管病分会.中国脑小血管病的神经影像学诊断标准及名词标准化定义--来自中国卒中学会的专家共识[J].中国卒中杂志, 2024, 19:375-404.] [13] Zhu YC. Interpretation of the STandards for ReportIng Vascular changes on nEuroimaging 2(STRIVE-2)[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2023, 23:955-958.[朱以诚.脑小血管病影像学诊断标准的更新解读[J].中国现代神经疾病杂志, 2023, 23:955-958.] [14] Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging[J]. AJR Am J Roentgenol, 1987, 149:351-356. [15] Choi HS, Cho YM, Kang JH, Shin CS, Park KS, Lee HK. Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans[J]. Clin Endocrinol (Oxf), 2009, 71:184-188. [16] King KS, Peshock RM, Rossetti HC, McColl RW, Ayers CR, Hulsey KM, Das SR. Effect of normal aging versus hypertension, abnormal body mass index, and diabetes mellitus on white matter hyperintensity volume[J]. Stroke, 2014, 45:255-257. [17] Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease:meta-analysis of effects on lipids and haemostatic factors[J]. BMJ, 1999, 319:1523-1528. [18] Writing Group for Chinese Consensus on Diagnosis and Therapy of Cerebral Small Vessel Disease, Cerebral Small Vessel Disease Professional Committee, Chinese Research Hospital Assoction. Chinese expert consensus on diagnosis and therapy of cerebral small vessel disease 2021[J]. Zhongguo Zu Zhong Za Zhi, 2021, 16:716-726.[中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组.中国脑小血管病诊治专家共识2021[J].中国卒中杂志, 2021, 16:716-726.] Bots ML, Grobbee DE, [19] Breteler MMB, van Swieten JC, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HLJ, de Jong PTVM, van Gijn J, Hofman A. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study:the Rotterdam Study[J]. Neurology, 1994, 44:1246-1252. [20] Giese AK, Schirmer MD, Dalca AV, Sridharan R, Donahue KL, Nardin M, Irie R, McIntosh EC, Mocking SJT, Xu H, Cole JW, Giralt-Steinhauer E, Jimenez-Conde J, Jern C, Kleindorfer DO, Lemmens R, Wasselius J, Lindgren A, Rundek T, Sacco RL, Schmidt R, Sharma P, Slowik A, Thijs V, Worrall BB, Woo D, Kittner SJ, McArdle PF, Mitchell BD, Rosand J, Meschia JF, Wu O, Golland P, Rost NS; International Stroke Genetics Consortium and the MRI-GENIE Investigators. White matter hyperintensity burden in acute stroke patients differs by ischemic stroke subtype[J]. Neurology, 2020, 95:e79-e88. [21] Cloonan L, Fitzpatrick KM, Kanakis AS, Furie KL, Rosand J, Rost NS. Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke[J]. Atherosclerosis, 2015, 240:149-153. [22] Hiremath N, Kate M, Mohimen A, Kesavadas C, Sylaja PN. Risk factors of white matter hyperintensities in South Asian patients with transient ischemic attack and minor stroke[J]. Neuroradiology, 2020, 62:1279-1284. [23] Feng Z, Fang C, Ma Y, Chang J. Obesity-induced blood-brain barrier dysfunction:phenotypes and mechanisms[J]. J Neuroinflammation, 2024, 21:110. [24] Wardlaw JM, Benveniste H, Nedergaard M, Zlokovic BV, Mestre H, Lee H, Doubal FN, Brown R, Ramirez J, MacIntosh BJ, Tannenbaum A, Ballerini L, Rungta RL, Boido D, Sweeney M, Montagne A, Charpak S, Joutel A, Smith KJ, Black SE; Colleagues from the Fondation Leducq Transatlantic Network of Excellence on the Role of the Perivascular Space in Cerebral Small Vessel Disease. Perivascular spaces in the brain:anatomy, physiology and pathology[J]. Nat Rev Neurol, 2020, 16:137-153. [25] Rajani RM, Quick S, Ruigrok SR, Graham D, Harris SE, Verhaaren BFJ, Fornage M, Seshadri S, Atanur SS, Dominiczak AF, Smith C, Wardlaw JM, Williams A. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats[J]. Sci Transl Med, 2018, 10:eaam9507. [26] Kong QQ, Huang H, Luo X. Research progress on the correlation between blood-brain barrier and cerebral small vessel disease[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2023, 23:972-977.[孔倩倩,黄浩,骆翔.血脑屏障与脑小血管病相关研究进展[J].中国现代神经疾病志, 2023, 23:972-977.] [27] Alqarni A, Jiang J, Crawford JD, Koch F, Brodaty H, Sachdev P, Wen W. Sex differences in risk factors for white matter hyperintensities in non-demented older individuals[J]. Neurobiol Aging, 2021, 98:197-204. [28] de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM. Prevalence of cerebral white matter lesions in elderly people:a population based magnetic resonance imaging study. The Rotterdam Scan Study[J]. J Neurol Neurosurg Psychiatry, 2001, 70:9-14. [29] Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities[J]. Neurobiol Aging, 2009, 30:946-956. [30] van den Heuvel DM, Admiraal-Behloul F, ten Dam VH, Olofsen H, Bollen EL, Murray HM, Blauw GJ, Westendorp RG, de Craen AJ, van Buchem MA; PROSPER Study Group. Different progression rates for deep white matter hyperintensities in elderly men and women[J]. Neurology, 2004, 63:1699-1701. [31] Lohner V, Pehlivan G, Sanroma G, Miloschewski A, Schirmer MD, Stöcker T, Reuter M, Breteler MMB. Relation between sex, menopause, and white matter hyperintensities:the Rhineland study[J]. Neurology, 2022, 99:e935-e943. [32] Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J]. Lancet Neurol, 2013, 12:822-838. [33] Wu X, Zhang L, Miao Y, Yang J, Wang X, Wang CC, Feng J, Wang L. Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis[J]. Redox Biol, 2019, 20:46-59. [34] Mohammad G, Kowluru RA. Homocysteine disrupts balance between MMP-9 and its tissue inhibitor in diabetic retinopathy:the role of DNA methylation[J]. Int J Mol Sci, 2020, 21:1771. [35] Yang J, Cao Z, Jiang J, Zhou Y, Zhu X. Association between H-type hypertension and white matter hyperintensity in patients with acute ischemic stroke[J]. Curr Neurovasc Res, 2023, 20:190-196. [36] Cai J, Sun J, Chen H, Chen Y, Zhou Y, Lou M, Yu R. Different mechanisms in periventricular and deep white matter hyperintensities in old subjects[J]. Front Aging Neurosci, 2022, 14:940538. [37] Mukamal KJ, Longstreth WT Jr, Mittleman MA, Crum RM, Siscovick DS. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults:the cardiovascular health study[J]. Stroke, 2001, 32:1939-1946. [38] Chen X, Duan L, Han Y, Tian L, Dai Q, Wang S, Lin Y, Xiong Y, Liu X. Predictors for vascular cognitive impairment in stroke patients[J]. BMC Neurol, 2016, 16:115. [39] Lee KP, Chang AYW, Sung PS. Association between blood pressure, blood pressure variability, and post-stroke cognitive impairment[J]. Biomedicines, 2021, 9:773. [40] Oksala NK, Salonen T, Strandberg T, Oksala A, Pohjasvaara T, Kaste M, Karhunen PJ, Erkinjuntti T. Cerebral small vessel disease and kidney function predict long-term survival in patients with acute stroke[J]. Stroke, 2010, 41:1914-20. [41] Zong L, Yao M, Ni J, Zhou L, Yuan J, Peng B, Zhu YC, Cui L. Kidney function is associated with severity of white matter hyperintensity in patients with acute ischemic stroke/TIA[J]. BMC Neurol, 2016, 16:193. [42] O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney:cause and logic of therapy[J]. Hypertension, 2005, 46:200-204. |